Cargando…

Changing patterns of invasive meningococcal disease and future immunization strategies

Invasive meningococcal disease (IMD) is a life-threatening disease caused by Neisseria meningitidis and has high mortality rates. Survivors often exhibit long-term sequelae and reduced life expectancy. Disease incidence is highest in infants and toddlers, with a resurgence of cases in adolescents an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taha, Muhamed-Kheir, Bekkat-Berkani, Rafik, Abitbol, Véronique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Meningococcal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101658/ https://www.ncbi.nlm.nih.gov/pubmed/37017273 http://dx.doi.org/10.1080/21645515.2023.2186111

Ejemplares similares

Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations
por: Martinón-Torres, Federico, et al.
Publicado: (2021)

Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
por: Abitbol, Véronique, et al.
Publicado: (2023)

Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam
por: The Nguyen, Phung Nguyen, et al.
Publicado: (2023)

Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
por: Weil-Olivier, Catherine, et al.
Publicado: (2022)

Meningococcal disease within the Gulf Cooperation Council Countries
por: Al Awaidy, Salah, et al.
Publicado: (2023)

Meningococcal burden of disease in Argentina: 10 years epidemiologic review
por: Neyro, Silvina, et al.
Publicado: (2023)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Sow, Samba O., et al.
Publicado: (2023)

Pandemic’s influence on parents’ attitudes and behaviors toward meningococcal vaccination
por: Tan, Litjen (L.J), et al.
Publicado: (2023)

Preventing invasive meningococcal disease in early infancy
por: Presa, Jessica, et al.
Publicado: (2022)

A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine
por: Ruiz Garcia, Yara, et al.
Publicado: (2021)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
por: Presa, Jessica, et al.
Publicado: (2023)

Correction to: A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine
por: Ruiz Garcia, Yara, et al.
Publicado: (2021)

Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis
por: Packnett, Elizabeth R., et al.
Publicado: (2023)

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
por: Dubey, Anand P., et al.
Publicado: (2022)

Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination
por: Soumahoro, Lamine, et al.
Publicado: (2021)

Vaccines against Meningococcal Diseases
por: Pizza, Mariagrazia, et al.
Publicado: (2020)

Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study
por: Robertson, Corwin A., et al.
Publicado: (2023)

Product review on the IMD serogroup B vaccine Bexsero®
por: Deghmane, Ala-Eddine, et al.
Publicado: (2022)

Meningococcal carriage in the African meningitis belt
Publicado: (2013)

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
por: Ruiz García, Yara, et al.
Publicado: (2021)

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
por: Knuf, Markus, et al.
Publicado: (2022)

Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis
por: Xu, Juan, et al.
Publicado: (2022)

Range of invasive meningococcal disease sequelae and health economic application – a systematic and clinical review
por: Shen, Jing, et al.
Publicado: (2022)

Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico
por: Chacon-Cruz, Enrique, et al.
Publicado: (2022)

Invasive meningococcal disease in Malaysia, Philippines, Thailand, and Vietnam: An Asia-Pacific expert group perspective on current epidemiology and vaccination policies
por: Thisyakorn, Usa, et al.
Publicado: (2022)

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age
por: Marshall, Gary S., et al.
Publicado: (2022)

Real-world impact and effectiveness of MenACWY-TT
por: Villena, Rodolfo, et al.
Publicado: (2023)

Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease
por: Taha, Muhamed-Kheir, et al.
Publicado: (2020)

Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries
por: Taha, Muhamed-Kheir, et al.
Publicado: (2020)

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study
por: Piazza, Franco M., et al.
Publicado: (2021)

Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014–19
por: Stefanizzi, Pasquale, et al.
Publicado: (2021)

Determinants of Meningococcal Vaccination Coverage and Adherence: A Targeted Literature Review Supporting a 16-year-old Healthcare Visit
por: Herrera-Restrepo, Oscar, et al.
Publicado: (2023)

Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
por: Taha, Muhamed-Kheir, et al.
Publicado: (2021)

Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database
por: Weil-Olivier, Catherine, et al.
Publicado: (2021)

Range of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review
por: Bertrand-Gerentes, Isabelle, et al.
Publicado: (2023)

Long-term impact of invasive meningococcal disease in children: SEINE study protocol
por: Baloche, Alexiane, et al.
Publicado: (2022)

Late Repression of NF-κB Activity by Invasive but Not Non-Invasive Meningococcal Isolates Is Required to Display Apoptosis of Epithelial Cells
por: Deghmane, Ala-Eddine, et al.
Publicado: (2011)

Influenza: Can we cope better with the unpredictable?
por: Dos Santos, Gaël, et al.
Publicado: (2015)

Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review
por: Dos Santos, Gael, et al.
Publicado: (2018)

Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination
por: Collard, Jean-Marc, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ghogkgha3cicc0c8kjeebuhbrc